ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      58,654.80
      1.32%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Adicet Bio Inc (ACET)

      7. Adicet Bio Inc (ACET) News

      ACET

      Adicet Bio (ACET)

      Adicet Bio Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ACET
      DateTimeSourceHeadlineSymbolCompany
      01/26/20247:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
      01/26/20247:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
      01/25/20244:01PMBusiness WireAdicet Bio, Inc. Announces Closing of $98 Million Public Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional SharesNASDAQ:ACETAdicet Bio Inc
      01/24/20244:34PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACETAdicet Bio Inc
      01/24/20244:32PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ACETAdicet Bio Inc
      01/22/202411:43PMBusiness WireAdicet Bio, Inc. Announces Pricing of Public OfferingNASDAQ:ACETAdicet Bio Inc
      01/22/20244:30PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ACETAdicet Bio Inc
      01/22/20244:28PMBusiness WireAdicet Bio, Inc. Announces Proposed Public OfferingNASDAQ:ACETAdicet Bio Inc
      01/19/20244:05PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ACETAdicet Bio Inc
      01/16/20247:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACETAdicet Bio Inc
      01/04/20247:17AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACETAdicet Bio Inc
      01/04/20247:00AMBusiness WireAdicet Provides Corporate Update and Highlights Strategic Priorities for 2024NASDAQ:ACETAdicet Bio Inc
      01/03/20244:01PMBusiness WireAdicet Bio to Host Conference Call to Provide Updates on its Clinical Pipeline and Corporate OutlookNASDAQ:ACETAdicet Bio Inc
      12/29/20234:50PMBusiness WireAdicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACETAdicet Bio Inc
      12/10/202312:00PMBusiness WireAdicet Bio Highlights ADI-001 Expansion, Persistence and Pharmacodynamic Profile from Ongoing Phase 1 Study at the 65th American Society of Hematology (ASH) Annual MeetingNASDAQ:ACETAdicet Bio Inc
      11/13/20234:42PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACETAdicet Bio Inc
      11/08/20234:14PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ACETAdicet Bio Inc
      11/08/20234:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACETAdicet Bio Inc
      11/08/20234:10PMBusiness WireAdicet Reports Third Quarter 2023 Financial Results and Provides Business UpdatesNASDAQ:ACETAdicet Bio Inc
      11/07/20237:00AMBusiness WireAdicet Bio to Present at the 2023 Jefferies London Healthcare ConferenceNASDAQ:ACETAdicet Bio Inc
      11/02/20239:00AMBusiness WireAdicet Bio Announces Poster Presentation Highlighting ADI-001 Data at the 65th American Society of Hematology (ASH) Annual MeetingNASDAQ:ACETAdicet Bio Inc
      10/31/20236:25PMBusiness WireAdicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACETAdicet Bio Inc
      10/16/20234:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
      10/04/202312:00PMBusiness WireAdicet Bio Announces Poster Presentation at the Upcoming 2023 Molecular Targets and Cancer Therapeutics ConferenceNASDAQ:ACETAdicet Bio Inc
      10/03/20234:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
      09/29/20235:24PMBusiness WireAdicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACETAdicet Bio Inc
      09/27/20239:00AMBusiness WireAdicet Bio to Present Three Scientific Posters Highlighting its Allogeneic Gamma Delta T Cell Platform and Programs at the Society for Immunotherapy of Cancer (SITC) 38th Annual MeetingNASDAQ:ACETAdicet Bio Inc
      08/31/20234:35PMBusiness WireAdicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACETAdicet Bio Inc
      08/16/20236:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
      08/16/20236:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
       Showing the most relevant articles for your search:NASDAQ:ACET